Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Nov;19(11):1551-7.
doi: 10.1007/s00192-008-0688-6. Epub 2008 Aug 7.

Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women

Rebecca Rogers  1 , Gloria Bachmann, Zhanna Jumadilova, Franklin Sun, Jon D Morrow, Zhonghong Guan, Tamara Bavendam
Affiliations
Randomized Controlled Trial

Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women

Rebecca Rogers et al. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Nov.

Abstract

We evaluated overactive bladder (OAB) symptoms and sexual and emotional health in sexually active women with OAB/urgency urinary incontinence (UUI) treated with tolterodine extended release (ER). Sexually active women with OAB symptoms were randomized to placebo or tolterodine ER. Five-day bladder diaries, Sexual Quality of Life Questionnaire-Female (SQOL-F), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ), and Hospital Anxiety and Depression Scale (HAD) were completed at baseline and week 12. Tolterodine ER (n = 201; mean +/- SD age, 49 +/- 12 years) reduced UUI episodes (P = 0.0029), total (P = 0.0006) and OAB (P < 0.0001) micturitions, and pad use per 24 h (P = 0.0024), and was associated with improvements in SQOL-F (P = 0.004), PISQ total (P = 0.009), and HAD Anxiety (P = 0.03) scores versus placebo (n = 210; mean +/- SD age, 47 +/- 12 years). OAB symptoms improved with tolterodine ER as did the scores of sexual health and anxiety measures in sexually active women with OAB.

Trial registration: ClinicalTrials.gov NCT00143481.

PubMed Disclaimer

References

    1. Am J Obstet Gynecol. 2006 Dec;195(6):1730-5 - PubMed
    1. Urology. 2001 Jun;57(6):1044-50 - PubMed
    1. Urology. 2006 Aug;68(2 Suppl):9-16 - PubMed
    1. Eur Urol. 2004 May;45(5):642-8; discussion 648 - PubMed
    1. Am J Manag Care. 2002 Dec;8(19 Suppl):S608-15 - PubMed

Publication types

MeSH terms

Associated data